Results
|
|
981.
|
|
|
|
982.
|
|
|
|
983.
|
|
|
|
984.
|
Optimal tolerability and high efficacy of a modified schedule of lapatinib-capecitabine in advanced breast cancer patients. [electronic resource] by
- Gamucci, T
- Moscetti, L
- Mentuccia, L
- Pizzuti, L
- Mauri, M
- Zampa, G
- Pavese, I
- Sperduti, I
- Vaccaro, A
- Vici, P
Producer: 20140325
In:
Journal of cancer research and clinical oncology vol. 140
Availability: No items available.
|
|
|
985.
|
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial. [electronic resource] by
- Azim, Hatem A
- Rothé, Francoise
- Aura, Claudia Monica
- Bavington, Malcolm
- Maetens, Marion
- Rouas, Ghizlaine
- Gebhart, Geraldine
- Gamez, Cristina
- Eidtmann, Holger
- Baselga, José
- Piccart-Gebhart, Martine
- Ellis, Catherine
- Vuylsteke, Peter
- Cure, Hervé
- Domont, Julien
- Ferro, Antonella
- Toral-Peña, Juan Carlos
- de Azambuja, Evandro
- Sotiriou, Christos
- Di Cosimo, Serena
- Ignatiadis, Michail
Producer: 20141031
In:
Breast (Edinburgh, Scotland) vol. 22
Availability: No items available.
|
|
|
986.
|
Metabolic shifts in residual breast cancer drive tumor recurrence. [electronic resource] by
- Havas, Kristina M
- Milchevskaya, Vladislava
- Radic, Ksenija
- Alladin, Ashna
- Kafkia, Eleni
- Garcia, Marta
- Stolte, Jens
- Klaus, Bernd
- Rotmensz, Nicole
- Gibson, Toby J
- Burwinkel, Barbara
- Schneeweiss, Andreas
- Pruneri, Giancarlo
- Patil, Kiran R
- Sotillo, Rocio
- Jechlinger, Martin
Producer: 20170926
In:
The Journal of clinical investigation vol. 127
Availability: No items available.
|
|
|
987.
|
|
|
|
988.
|
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. [electronic resource] by
- Rimawi, Mothaffar F
- De Angelis, Carmine
- Contreras, Alejandro
- Pareja, Fresia
- Geyer, Felipe C
- Burke, Kathleen A
- Herrera, Sabrina
- Wang, Tao
- Mayer, Ingrid A
- Forero, Andres
- Nanda, Rita
- Goetz, Matthew P
- Chang, Jenny C
- Krop, Ian E
- Wolff, Antonio C
- Pavlick, Anne C
- Fuqua, Suzanne A W
- Gutierrez, Carolina
- Hilsenbeck, Susan G
- Li, Marilyn M
- Weigelt, Britta
- Reis-Filho, Jorge S
- Kent Osborne, C
- Schiff, Rachel
Producer: 20181024
In:
Breast cancer research and treatment vol. 167
Availability: No items available.
|
|
|
989.
|
|
|
|
990.
|
|
|
|
991.
|
|
|
|
992.
|
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. [electronic resource] by
- Bachelot, Thomas
- Romieu, Gilles
- Campone, Mario
- Diéras, Véronique
- Cropet, Claire
- Dalenc, Florence
- Jimenez, Marta
- Le Rhun, Emilie
- Pierga, Jean-Yves
- Gonçalves, Anthony
- Leheurteur, Marianne
- Domont, Julien
- Gutierrez, Maya
- Curé, Hervé
- Ferrero, Jean-Marc
- Labbe-Devilliers, Catherine
Producer: 20130403
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
993.
|
|
|
|
994.
|
|
|
|
995.
|
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01. [electronic resource] by
- Parham, L R
- Briley, L P
- Li, L
- Shen, J
- Newcombe, P J
- King, K S
- Slater, A J
- Dilthey, A
- Iqbal, Z
- McVean, G
- Cox, C J
- Nelson, M R
- Spraggs, C F
Producer: 20161006
In:
The pharmacogenomics journal vol. 16
Availability: No items available.
|
|
|
996.
|
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. [electronic resource] by
- Stuhlmiller, Timothy J
- Miller, Samantha M
- Zawistowski, Jon S
- Nakamura, Kazuhiro
- Beltran, Adriana S
- Duncan, James S
- Angus, Steven P
- Collins, Kyla A L
- Granger, Deborah A
- Reuther, Rachel A
- Graves, Lee M
- Gomez, Shawn M
- Kuan, Pei-Fen
- Parker, Joel S
- Chen, Xin
- Sciaky, Noah
- Carey, Lisa A
- Earp, H Shelton
- Jin, Jian
- Johnson, Gary L
Producer: 20160126
In:
Cell reports vol. 11
Availability: No items available.
|
|
|
997.
|
A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. [electronic resource] by
- Wei, Yan
- Xu, Shuai
- Wang, Feng
- Zou, Aifeng
- Zhang, Shuang
- Xiong, Yan
- Cao, Shilei
- Zhang, Qizhi
- Wang, Yajie
- Jiang, Xinguo
Producer: 20150908
In:
Journal of pharmaceutical sciences vol. 104
Availability: No items available.
|
|
|
998.
|
|
|
|
999.
|
|
|
|
1000.
|
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy. [electronic resource] by
- Kim, Sung-Bae
- Do, In-Gu
- Tsang, Janice
- Kim, Tae-You
- Yap, Yoon-Sim
- Cornelio, Gerardo
- Gong, Gyungyub
- Paik, Soonmyung
- Lee, Suee
- Ng, Ting-Ying
- Park, Sarah
- Oh, Ho-Suk
- Chiu, Joanne
- Sohn, Joohyuk
- Lee, Moonhee
- Choi, Young-Jin
- Lee, Eun Mi
- Park, Kyong-Hwa
- Nathaniel, Christos
- Ro, Jungsil
Producer: 20200218
In:
Cancer research and treatment vol. 51
Availability: No items available.
|